Old Web
English
Sign In
Acemap
>
authorDetail
>
Dirk J. Richel
Dirk J. Richel
Medicine
Pathology
Clinical endpoint
Phases of clinical research
Survival analysis
2
Papers
1321
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Chemotherapy, Bevacizumab, and Cetuximab in Metastatic Colorectal Cancer
2009
The New England Journal of Medicine
Jolien Tol
M. Koopman
Annemieke Cats
C.J Rodenburg
Geert Jan Creemers
Jolanda G. Schrama
Frans Erdkamp
Allert H. Vos
Cees J. van Groeningen
Harm Sinnige
Dirk J. Richel
Emile E. Voest
Jeroen R. Dijkstra
Marianne E. Vink-Börger
Ninja Antonini
Linda Mol
Johan H. J. M. van Krieken
Otilia Dalesio
Cornelis J. A. Punt
Show All
Source
Cite
Save
Citations (1143)
A single-arm, multicenter, open-label phase 2 study of lapatinib as the second-line treatment of patients with locally advanced or metastatic transitional cell carcinoma
2009
Cancer
Christian Wülfing
Jean-Pascal Machiels
Dirk J. Richel
Marc-Oliver Grimm
Uwe Treiber
Marco R. de Groot
Philippe Beuzeboc
R. Parikh
Frank Pétavy
Iman El-Hariry
Show All
Source
Cite
Save
Citations (178)
1